Bharat Immunological & Biological Corporation Ltd
About
[
edit
]
Bharat Immunologicals and Biologicals Corporation is an India-based biotechnology company. The Company manufactures and produces a range of pharmaceuticals products, such as Oral Polio Vaccines (OPV Vaccine), Zinc Tablet and Diarrhea Management Kit (Zinc Tablet + oral rehydration salts (ORS)).
[
add key points
]
- Market Cap ₹ 259 Cr.
- Current Price ₹ 60.0
- High / Low ₹ 87.6 / 5.41
- Stock P/E
- Book Value ₹ 3.23
- Dividend Yield 0.00 %
- ROCE -21.9 %
- ROE -39.9 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Debtor days have improved from 193.92 to 96.16 days.
Cons
- Stock is trading at 18.61 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -14.49% over past five years.
- Company has a low return on equity of -20.41% for last 3 years.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
21.68 | 0.09 | 4.67 | 8.28 | 70.61 | 7.00 | 8.10 | 28.48 | 23.25 | 19.15 | 25.36 | 25.20 | |
25.96 | 1.53 | 8.28 | 7.82 | 74.94 | 12.73 | 14.79 | 30.50 | 19.21 | 18.52 | 29.86 | 27.47 | |
Operating Profit | -4.28 | -1.44 | -3.61 | 0.46 | -4.33 | -5.73 | -6.69 | -2.02 | 4.04 | 0.63 | -4.50 | -2.27 |
OPM % | -19.74% | -1,600.00% | -77.30% | 5.56% | -6.13% | -81.86% | -82.59% | -7.09% | 17.38% | 3.29% | -17.74% | -9.01% |
Other Income | 0.62 | 0.34 | 0.10 | 0.10 | 2.09 | 1.84 | 0.17 | 0.47 | -1.31 | -0.58 | 0.14 | 1.20 |
Interest | 0.38 | 0.04 | 0.09 | 0.44 | 0.93 | 0.90 | 1.25 | 1.60 | 0.99 | 1.09 | 1.17 | 1.30 |
Depreciation | 0.05 | 0.10 | 0.10 | 0.10 | -0.03 | 0.20 | 0.06 | 0.06 | -0.08 | 0.06 | 0.06 | 0.06 |
Profit before tax | -4.09 | -1.24 | -3.70 | 0.02 | -3.14 | -4.99 | -7.83 | -3.21 | 1.82 | -1.10 | -5.59 | -2.43 |
Tax % | 68.22% | 33.87% | 32.16% | 0.00% | 28.34% | 30.86% | 27.59% | 26.48% | -106.59% | 29.09% | 30.77% | 21.81% |
Net Profit | -1.31 | -0.83 | -2.51 | 0.02 | -2.24 | -3.46 | -5.66 | -2.35 | 3.76 | -0.78 | -3.87 | -1.89 |
EPS in Rs | -0.30 | -0.19 | -0.58 | 0.00 | -0.52 | -0.80 | -1.31 | -0.54 | 0.87 | -0.18 | -0.90 | -0.44 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6.84 | 2.50 | 2.56 | 46.34 | 172.80 | 202.75 | 146.22 | 128.03 | 124.19 | 34.80 | 83.65 | 66.84 | 92.96 | |
9.68 | 6.30 | 6.48 | 40.73 | 163.55 | 190.68 | 142.81 | 131.95 | 111.36 | 42.73 | 92.97 | 77.24 | 95.06 | |
Operating Profit | -2.84 | -3.80 | -3.92 | 5.61 | 9.25 | 12.07 | 3.41 | -3.92 | 12.83 | -7.93 | -9.32 | -10.40 | -2.10 |
OPM % | -41.52% | -152.00% | -153.12% | 12.11% | 5.35% | 5.95% | 2.33% | -3.06% | 10.33% | -22.79% | -11.14% | -15.56% | -2.26% |
Other Income | 1.03 | 1.79 | 1.15 | 2.00 | 1.08 | 6.01 | 0.73 | 1.30 | 1.18 | 1.39 | 4.22 | 1.18 | -0.55 |
Interest | 0.03 | 0.00 | 0.03 | 0.41 | 2.20 | 6.03 | 1.13 | 5.69 | 4.21 | 1.01 | 2.00 | 4.75 | 4.55 |
Depreciation | 1.78 | 1.56 | 1.37 | 1.24 | 1.26 | 1.04 | 0.91 | 0.65 | 0.58 | 0.41 | 0.28 | 0.24 | 0.10 |
Profit before tax | -3.62 | -3.57 | -4.17 | 5.96 | 6.87 | 11.01 | 2.10 | -8.96 | 9.22 | -7.96 | -7.38 | -14.21 | -7.30 |
Tax % | 2.49% | -146.22% | 0.00% | -110.74% | 27.07% | 41.78% | 26.19% | 30.69% | 29.39% | 46.48% | 21.41% | 28.08% | |
Net Profit | -3.53 | -8.79 | -4.17 | 12.56 | 5.02 | 6.41 | 1.55 | -6.21 | 6.51 | -4.26 | -5.79 | -10.21 | -2.78 |
EPS in Rs | -0.82 | -2.04 | -0.97 | 2.91 | 1.16 | 1.48 | 0.36 | -1.44 | 1.51 | -0.99 | -1.34 | -2.36 | -0.65 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 39% |
5 Years: | -14% |
3 Years: | -19% |
TTM: | -19% |
Compounded Profit Growth | |
---|---|
10 Years: | -2% |
5 Years: | % |
3 Years: | % |
TTM: | 80% |
Stock Price CAGR | |
---|---|
10 Years: | 16% |
5 Years: | 27% |
3 Years: | 42% |
1 Year: | 617% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | -11% |
3 Years: | -20% |
Last Year: | -40% |
Balance Sheet
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
Reserves | -14.27 | -23.06 | -27.23 | -14.83 | -1.23 | -3.41 | -1.87 | -8.07 | -1.43 | -5.69 | -12.50 | -22.71 | -29.25 |
Borrowings | 0.57 | 0.52 | 0.00 | 7.13 | 0.00 | -1.13 | -8.84 | 9.42 | 0.06 | 0.00 | 32.22 | 3.04 | 38.93 |
6.14 | 7.10 | 14.60 | 45.06 | 47.85 | 52.42 | 47.80 | 23.86 | 17.09 | 15.91 | 62.06 | 103.32 | 36.14 | |
Total Liabilities | 35.62 | 27.74 | 30.55 | 80.54 | 89.80 | 91.06 | 80.27 | 68.39 | 58.90 | 53.40 | 124.96 | 126.83 | 89.00 |
12.52 | 11.10 | 9.76 | 8.54 | 7.74 | 6.76 | 6.05 | 5.50 | 5.36 | 4.95 | 4.70 | 4.47 | 4.29 | |
CWIP | 1.13 | 0.57 | 0.57 | 0.59 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
21.97 | 16.07 | 20.22 | 71.41 | 81.84 | 84.08 | 74.00 | 62.67 | 53.32 | 48.23 | 120.04 | 122.14 | 84.49 | |
Total Assets | 35.62 | 27.74 | 30.55 | 80.54 | 89.80 | 91.06 | 80.27 | 68.39 | 58.90 | 53.40 | 124.96 | 126.83 | 89.00 |
Cash Flows
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-2.34 | -3.20 | -3.00 | 4.97 | 31.35 | -11.87 | 7.80 | -9.35 | -17.00 | 2.52 | -32.10 | 34.08 | |
-0.74 | 0.42 | -0.02 | -0.04 | 0.37 | 0.32 | 0.45 | 1.36 | 0.50 | -0.85 | 0.70 | 0.91 | |
-0.62 | 0.54 | 8.74 | -2.78 | -0.30 | -6.42 | -1.36 | -2.12 | -3.33 | -0.79 | 30.61 | -34.41 | |
Net Cash Flow | -3.70 | -2.24 | 5.72 | 2.15 | 31.42 | -17.97 | 6.88 | -10.12 | -19.83 | 0.89 | -0.79 | 0.58 |
Ratios
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | -11.60% | -14.25% | -22.63% | 20.49% | 22.60% | 42.04% | 9.08% | -8.26% | 31.11% | -17.53% | -10.72% | -21.90% |
Debtor Days | 85.38 | 233.60 | 152.56 | 209.28 | 2.28 | 47.17 | 34.20 | 37.29 | 18.96 | 167.19 | 318.40 | 96.16 |
Inventory Turnover | 7.37 | 0.39 | 0.86 | 2.92 | 5.25 | 5.43 | 4.08 | 4.51 | 8.01 | 27.00 | 10.02 | 1.91 |
Documents
Add documentRecent announcements
- Submission Of Limited Review Report Of The Quarterly Unaudited Financial Results For The Quarter Ended December 2020 Under Regulation 33(3)(C ) Of LODR 15 Feb
- Submission Of Unaudited Quarterly Financial Results (UAFR) For The Quarter Ended December 2020 11 Feb
- Board Meeting Intimation for Intimation Of Date Of Board Meeting On 10Th February 2021 For The Quarter Ended December 2020, Under Regulation 29 Of SEBI'S LODR 3 Feb
- Shareholding for the Period Ended December 31, 2020 11 Jan
- Statement Of Investor Complaints For The Quarter Ended December 2020 11 Jan
View all